心臓マッピング市場規模、シェア、成長分析：タイプ別、適応症別、エンドユーザー別、地域別 - 産業予測 2025～2032年

心臓マッピングの世界市場規模は、2023年に19億8,000万米ドルと評価され、2024年の21億6,000万米ドルから2032年には42億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.9％で成長する見通しです。

市場の洞察によると、現在約1,400万人の米国人が心臓リズム障害に罹患しており、健康上の重大な課題を浮き彫りにしています。この広範な問題に対応するため、心臓マッピングシステムは高度で非侵襲的なソリューションとして登場しました。この最先端技術は、胸部からの電気インパルスをとらえ、これらの信号をCTスキャンデータと統合して、詳細な心臓マップを作成します。この高解像度マップは専門医にとって不可欠であり、心臓の複雑なリズムパターンを徹底的に分析することができます。心臓マッピングを活用することで、ヘルスケア専門家は心臓リズム障害に対する理解を深めることができ、より正確な診断と個別化された治療オプションにつながり、最終的にはこの心臓血管の健康における重要な分野における患者の転帰を改善することができます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

心臓マッピング市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 接触型心臓マッピングシステム
• 非接触型心臓マッピングシステム

心臓マッピング市場規模：適応症別& CAGR（2025-2032）

• 市場概要
• 心房細動
• 心房粗動
• 房室結節リエントリー性頻拍（AVNRT）
• その他の適応症

心臓マッピング市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院と診療所
• 診断センター
• その他のエンドユーザー

心臓マッピング市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Biosense Webster, Inc.（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Medtronic plc（Ireland）
• Acutus Medical, Inc.（USA）
• AngioDynamics（USA）
• Koninklijke Philips N.V.（Netherlands）
• Biosig Technologies, Inc.（USA）
• MicroPort Scientific Corporation（China）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Siemens Healthineers AG（Germany）
• GE Healthcare（USA）
• Johnson & Johnson（USA）
• St. Jude Medical, Inc.（USA）
• CardioInsight Technologies, Inc.（USA）
• EP Solutions SA（Switzerland）
• CathVision ApS（Denmark）
• Acutus Medical, Inc.（USA）
• MedLumics（Spain）

結論と提言

Global Cardiac Mapping Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.16 billion in 2024 to USD 4.26 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

Market insights indicate that around 14 million Americans are currently affected by heart rhythm disorders, highlighting a significant health challenge. In response to this widespread issue, cardiac mapping systems have emerged as an advanced, non-invasive solution. This cutting-edge technology captures electrical impulses from the chest and integrates these signals with computed tomography (CT) scan data to create detailed cardiac maps. These high-resolution maps are essential for specialists, allowing them to analyze the heart's complex rhythm patterns thoroughly. By utilizing cardiac mapping, healthcare professionals can enhance their understanding of heart rhythm disorders, leading to more precise diagnoses and personalized treatment options, ultimately improving patient outcomes in this critical area of cardiovascular health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Mapping Market Segments Analysis

Global Cardiac Mapping Market is segmented by Type, Indication, End User and region. Based on Type, the market is segmented into Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems. Based on Indication, the market is segmented into Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT) and Other Indications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is projected to experience significant revenue growth, driven by two primary factors: the increasing incidence of cardiovascular disorders and ongoing innovations in cardiac mapping technology. The World Health Organization (WHO) identifies cardiovascular diseases (CVDs) as the foremost cause of death worldwide, claiming around 17.9 million lives each year. Alarmingly, over 80% of deaths linked to CVDs result from heart attacks and strokes, with many victims under the age of 70. This growing health crisis, coupled with advancements in diagnostic tools, is expected to propel the demand for sophisticated cardiac mapping systems.

Restraints in the Global Cardiac Mapping Market

The Global Cardiac Mapping market faces a significant constraint due to the rising trend towards intricate treatment protocols in cardiac imaging. As medical practices evolve and the complexity of cardiac conditions increases, healthcare providers are compelled to adapt their methodologies to incorporate advanced imaging techniques and detailed mapping solutions. This shift may result in challenges for the established cardiac mapping technologies, which may struggle to keep pace with the demand for more sophisticated treatment options. Consequently, the need for continual innovation and adaptation in the cardiac mapping sector is critical to address the complexities of modern cardiac care effectively.

Market Trends of the Global Cardiac Mapping Market

The Global Cardiac Mapping market is poised for significant growth during the forecast period, fueled by advancements in diagnostic technologies and a rising demand for precise cardiac testing. Medical device companies are at the forefront, innovating and introducing state-of-the-art mapping solutions that enhance the ability to diagnose and treat cardiac conditions. The need for accurate and comprehensive cardiac assessments is escalating due to the increasing prevalence of cardiovascular diseases and aging populations. Additionally, the integration of artificial intelligence and machine learning in cardiac mapping systems is further accelerating market expansion, positioning the sector for robust development in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Cardiac Mapping Market Size by Type & CAGR (2025-2032)

• Market Overview
• Contact Cardiac Mapping Systems
• Non-Contact Cardiac Mapping Systems

Global Cardiac Mapping Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation
• Atrial Flutter
• Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
• Other Indications

Global Cardiac Mapping Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Other End Users

Global Cardiac Mapping Market Size & CAGR (2025-2032)

• North America (Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Biosense Webster, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosig Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioInsight Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EP Solutions SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CathVision ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedLumics (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations